妊娠期降压药物的安全性：在不确定性中生活。
Safety of Antihypertensive Medications in Pregnancy: Living With Uncertainty.
机构信息
Division of Nephrology and Hypertension Department of Medicine Weill Cornell Medicine New York NY.
出版信息
J Am Heart Assoc. 2019 Aug 6;8(15):e013495. doi: 10.1161/JAHA.119.013495. Epub 2019 Jul 26.
Abstract
See Article by Mito et al.
摘要
见 Mito 等人的文章。
相似文献
1
Safety of Antihypertensive Medications in Pregnancy: Living With Uncertainty.妊娠期降压药物的安全性：在不确定性中生活。
J Am Heart Assoc. 2019 Aug 6;8(15):e013495. doi: 10.1161/JAHA.119.013495. Epub 2019 Jul 26.
2
Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.一项苯磺酸氨氯地平和奥美沙坦酯合用的疗效和安全性研究的亚组分析：根据基线高血压阶段和既往降压药物使用情况进行评估。
J Cardiovasc Pharmacol. 2009 Nov;54(5):427-36. doi: 10.1097/FJC.0b013e3181bad74e.
3
Safety of Amlodipine in Early Pregnancy.氨氯地平在早孕中的安全性。
J Am Heart Assoc. 2019 Aug 6;8(15):e012093. doi: 10.1161/JAHA.119.012093. Epub 2019 Jul 26.
4
Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.奥美沙坦酯与氨氯地平治疗轻至中度高血压的降压疗效及安全性比较
J Hum Hypertens. 2003 Jun;17(6):425-32. doi: 10.1038/sj.jhh.1001577.
5
Management of chronic hypertension during pregnancy with furosemide, amlodipine or aspirin: a pilot clinical trial.妊娠期间使用呋塞米、氨氯地平或阿司匹林治疗慢性高血压：一项初步临床试验。
J Matern Fetal Neonatal Med. 2014 Sep;27(13):1291-4. doi: 10.3109/14767058.2013.852180. Epub 2013 Oct 31.
7
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.口服抗高血压药物在慢性高血压孕妇中的比较疗效和安全性：一项网络荟萃分析。
Am J Obstet Gynecol. 2020 Oct;223(4):525-537. doi: 10.1016/j.ajog.2020.03.016. Epub 2020 Mar 19.
8
Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy.2.5毫克/天和5毫克/天苯磺酸氨氯地平治疗初治或曾接受单药抗高血压治疗的高血压患者的疗效和安全性
J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):318-328. doi: 10.1177/1074248418769054. Epub 2018 Apr 12.
9
Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.马尼地平与氨氯地平治疗老年单纯收缩期高血压的降压疗效及安全性：MAISH研究
Clin Drug Investig. 2007;27(9):623-32. doi: 10.2165/00044011-200727090-00004.
10
Drug safety evaluation of amlodipine.氨氯地平的药物安全性评价。
Expert Opin Drug Saf. 2011 Sep;10(5):795-804. doi: 10.1517/14740338.2011.585966. Epub 2011 May 19.
引用本文的文献
1
Determining the Optimal Dosing of Methyldopa in Pregnancy-Induced Hypertension Using PBPK-PD Modeling.使用生理药代动力学-药效学（PBPK-PD）模型确定甲基多巴在妊娠高血压中的最佳剂量
Clin Pharmacokinet. 2025 Jun 14. doi: 10.1007/s40262-025-01523-2.
2
Amlodipine in the HRT cycle for frozen embryo transfer to correct uterine artery resistance in women with prior implantation failure: a randomized controlled trial.氨氯地平用于激素替代周期冷冻胚胎移植以纠正既往种植失败女性的子宫动脉阻力：一项随机对照试验。
Clin Exp Reprod Med. 2025 Jun;52(2):141-149. doi: 10.5653/cerm.2024.07129. Epub 2024 Dec 11.
3
The Role of Dietary Polyphenols in Pregnancy and Pregnancy-Related Disorders.膳食多酚在妊娠和妊娠相关疾病中的作用。
Nutrients. 2022 Dec 9;14(24):5246. doi: 10.3390/nu14245246.
4
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.妊娠对降压药代谢和药代动力学的影响：现状与未来方向。
Expert Opin Drug Metab Toxicol. 2021 Nov;17(11):1261-1279. doi: 10.1080/17425255.2021.2002845.
5
Pheochromocytoma as a rare hypertensive complication rarely associated with pregnancy: Diagnostic difficulties (Review).嗜铬细胞瘤作为一种罕见的高血压并发症，很少与妊娠相关：诊断困难（综述）
Exp Ther Med. 2021 Nov;22(5):1345. doi: 10.3892/etm.2021.10780. Epub 2021 Sep 22.
6
Neurocritical Care of the Pregnant Patient.妊娠患者的神经重症监护
Curr Treat Options Neurol. 2021;23(7):22. doi: 10.1007/s11940-021-00676-2. Epub 2021 Jun 21.
本文引用的文献
1
Safety of Amlodipine in Early Pregnancy.氨氯地平在早孕中的安全性。
J Am Heart Assoc. 2019 Aug 6;8(15):e012093. doi: 10.1161/JAHA.119.012093. Epub 2019 Jul 26.
2
ACOG Practice Bulletin No. 203 Summary: Chronic Hypertension in Pregnancy.美国妇产科医师学会实践公告第 203 号总结：妊娠期慢性高血压。
Obstet Gynecol. 2019 Jan;133(1):215-219. doi: 10.1097/AOG.0000000000003021.
3
Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice.妊娠期高血压疾病：国际实践的国际妊娠高血压研究学会分类、诊断及管理建议
Hypertension. 2018 Jul;72(1):24-43. doi: 10.1161/HYPERTENSIONAHA.117.10803.
4
In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review.子宫内暴露于抗高血压药物与新生儿及儿童健康结局：一项系统综述
J Hypertens. 2017 Nov;35(11):2123-2137. doi: 10.1097/HJH.0000000000001456.
5
Are hypertensive disorders in pregnancy associated with congenital malformations in offspring? Evidence from the WHO Multicountry cross sectional survey on maternal and newborn health.妊娠期高血压疾病与后代先天性畸形有关吗？来自世界卫生组织孕产妇和新生儿健康多国横断面调查的证据。
BMC Pregnancy Childbirth. 2016 Jul 29;16(1):198. doi: 10.1186/s12884-016-0987-8.
6
A Randomized Trial of Intensive versus Standard Blood-Pressure Control.强化与标准血压控制的随机试验
N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9.
7
Less-tight versus tight control of hypertension in pregnancy.妊娠期间的高血压，宽松控制与严格控制的比较。
N Engl J Med. 2015 Jan 29;372(5):407-17. doi: 10.1056/NEJMoa1404595.
8
Amlodipine passage into breast milk in lactating women with pregnancy-induced hypertension and its estimation of infant risk for breastfeeding.氨氯地平在妊娠高血压综合征哺乳期妇女乳汁中的转运及其对母乳喂养婴儿风险的评估。
J Hum Lact. 2015 May;31(2):301-6. doi: 10.1177/0890334414560195. Epub 2014 Dec 1.
9
Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study.母体高血压疾病、降压药物使用与出生缺陷风险：病例对照研究。
BJOG. 2015 Jun;122(7):1002-9. doi: 10.1111/1471-0528.13138. Epub 2014 Nov 14.
10
Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study.妊娠合并慢性高血压与先天性畸形风险：一项队列研究。
Am J Obstet Gynecol. 2015 Mar;212(3):337.e1-14. doi: 10.1016/j.ajog.2014.09.031. Epub 2014 Sep 28.
Zotero 插件